Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gsk Plc ADR (GSK)

Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gsk Plc ADR 79 New Oxford Street London X0 WC1A 1DG GBR

www.gsk.com Employees: 68,629 P: 44-20-8047-5000

Sector:

Medical

Description:

GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 124,709,680
Enterprise Value, $K 143,597,424
Shares Outstanding, K 2,038,406
Float, K 1,834,565
% Float 90.00%
Short Interest, K 17,722
Short Float 0.87%
Days to Cover 3.01
Short Volume Ratio 0.61
% of Insider Shareholders 10.00%
% of Institutional Shareholders 15.74%

Financials:

Annual Sales, $ 43,078 M
Annual Net Income, $ 7,538 M
Last Quarter Sales, $ 11,464 M
Last Quarter Net Income, $ 846,040 K
EBIT, $ 10,460 M
EBITDA, $ 15,442 M

Growth:

1-Year Return 66.53%
3-Year Return 76.02%
5-Year Return 81.05%
5-Year Revenue Growth -1.61%
5-Year Earnings Growth 21.72%
5-Year Dividend Growth -33.60%

Per-Share Information:

Most Recent Earnings 0.26 on 02/04/26
Next Earnings Date 04/29/26
Earnings Per Share ttm 4.52
EPS Growth vs. Prev Qtr -54.05%
EPS Growth vs. Prev Year 15.25%
Annual Dividend & Yield (Paid) 1.68 (2.74%)
Annual Dividend & Yield (Fwd) 1.70 (2.80%)
Most Recent Dividend 0.478 on 02/20/26
Next Ex-Dividends Date 02/20/26
Dividend Payable Date 04/09/26
Dividend Payout Ratio 37.25%

GSK Ratios

Ratio
Price/Earnings ttm 13.47
Price/Earnings forward 12.61
Price/Earnings to Growth 3.69
Return-on-Equity % 46.75%
Return-on-Assets % 11.53%
Profit Margin % 17.50%
Debt/Equity 1.11
Price/Sales 2.88
Price/Cash Flow 8.76
Price/Book 5.90
Book Value/Share 10.32
Interest Coverage 11.56
60-Month Beta 0.46

GSK Dividends

Date Value
02/20/26 $0.4780
11/14/25 $0.4260
08/15/25 $0.4220
05/16/25 $0.4270
02/21/25 $0.4000
11/15/24 $0.3690
08/16/24 $0.3850
05/16/24 $0.3770
02/22/24 $0.3970
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar